MLchartDataset catalogue

Methylmercaptopurine riboside

Term · Oncology and biomedicine · MLC-T-ONC-015137

A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation.

Table 1. Record
IdentifierMLC-T-ONC-015137
FieldOncology and biomedicine
AbbreviationMMPR
Synonymsmethylthioinosine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-015137",
  "term": "Methylmercaptopurine riboside",
  "field": "Oncology and biomedicine",
  "definition": "A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation.",
  "abbreviation": "MMPR",
  "synonyms": [
    "methylthioinosine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/methylmercaptopurine-riboside/"
}

Record 10,953 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.